Psychiatric disturbances in patients with progressive supranuclear palsy: a case-control study.

Abstract:

OBJECTIVES:To investigate the frequency and the different types of psychiatric disturbances in PSP patients using validated psychiatric instruments. METHODS:We conducted a case-control study using the Structured Clinical Interview (SCID-I) for DSM-IV to investigate psychiatric disorders in 28 PSP patients and 28 age and gender matched healthy controls. PSP severity was scored using the PSP rating scale; cognitive functions were assessed using the Montreal Cognitive Assessment scale and the Frontal Assessment Battery scale. RESULTS:SCID-I disclosed that psychiatric disturbances were more frequent in PSP patients (53%) than in healthy controls (17.8%) (p = 0.005). Psychiatric disorders in PSP patients were characterized by mood disorders. Depression due to PSP was the most frequent diagnosis and was found in 8 of the 15 patients with depressive disorders. None of the PSP patients had a diagnosis of other SCID-I disorders. No clinical or demographic differences were found when comparing PSP patients with and without psychiatric disturbances. CONCLUSIONS:Psychiatric disturbances, namely depressive disorders, were more frequent in PSP patients than in controls. A thorough evaluation of psychiatric disorders is important to insure appropriate treatment of PSP patients..

authors

Bloise MC,Berardelli I,Roselli V,Pasquini M,Stirpe P,Colosimo C,Berardelli A,Fabbrini G

doi

10.1016/j.parkreldis.2014.05.015

subject

Has Abstract

pub_date

2014-09-01 00:00:00

pages

965-8

issue

9

eissn

1353-8020

issn

1873-5126

pii

S1353-8020(14)00218-1

journal_volume

20

pub_type

临床试验,杂志文章
  • A physical therapy programme for functional motor symptoms: A telemedicine pilot study.

    abstract:INTRODUCTION:for a proportion of patients with functional motor symptoms (FMS), specific physiotherapy has recently emerged as a promising treatment. Aim of the present study was to assess in a sample of patients with FMS the efficacy of a physical therapy-based telemedicine programme on the motor symptoms themselves a...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2019.05.004

    authors: Demartini B,Bombieri F,Goeta D,Gambini O,Ricciardi L,Tinazzi M

    更新日期:2020-07-01 00:00:00

  • Comment on Akbar et al., "Valbenazine-induced parkinsonism".

    abstract::This letter to the editor acknowledges the contribution of Akbar et al. to the field of tardive dyskinesia (TD) and provides important regulatory information about the potential for parkinson-like symptoms in patients with TD who are treated with valbenazine. ...

    journal_title:Parkinsonism & related disorders

    pub_type: 评论,信件

    doi:10.1016/j.parkreldis.2020.01.011

    authors: Shah C

    更新日期:2020-02-01 00:00:00

  • Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease.

    abstract::The effectiveness of oral levodopa in complex Parkinson's disease (PD) is limited by its short half-life, and the resulting pulsatile dopaminergic stimulation leads to complex motor fluctuations and dyskinesia. Several treatments provide more continuous/less pulsatile dopaminergic stimulation by modifying the pharmaco...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2009.09.005

    authors: Clarke CE,Worth P,Grosset D,Stewart D

    更新日期:2009-12-01 00:00:00

  • Early Onset Parkinson's disease due to DJ1 mutations: An Indian study.

    abstract:INTRODUCTION:Early Onset Parkinson's Disease (EOPD) is genetically heterogeneous. PARK2 mutations are the commonest cause of autosomal recessive EOPD followed by PINK1.DJ1 mutations is rare and there is scarce literature on its phenotype and long term outcome. OBJECTIVES:We undertook a retrospective study to determine...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2016.04.024

    authors: Abbas MM,Govindappa ST,Sudhaman S,Thelma BK,Juyal RC,Behari M,Muthane UB

    更新日期:2016-11-01 00:00:00

  • Dystonic frowning without blepharospasm.

    abstract::We report on two cases who presented with involuntary facial grimacing and frowning. Blepharospasm has never been documented in one, and the other case showed difficulty in lid opening only in the early phase of the disease. Botulinum toxin was effective for both. This is a hitherto unreported presentation of upper fa...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2007.12.001

    authors: Hirota N,Hirota M,Mezaki T

    更新日期:2008-11-01 00:00:00

  • Non-motor extranigral signs and symptoms in Parkinson's disease.

    abstract::Clinical symptoms in Parkinson's disease (PD) comprise both motor and non-motor symptoms. In this disease, synucleinopathic-induced, nigral dopamine deficiency-related dysfunction of the basal ganglia is held responsible for the characteristic levodopa-responsive motor signs and symptoms (bradykinesia, hypokinesia, ri...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/S1353-8020(09)70770-9

    authors: Wolters ECh

    更新日期:2009-12-01 00:00:00

  • Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients.

    abstract:INTRODUCTION:Fatigue is one of the most common and disabling non-motor symptoms in Parkinson's disease (PD). The objective of this study was to determine prevalence and motor, behavioural, and cognitive correlates of distressing fatigue in early, de novo PD patients. METHODS:Eighty-one consecutive de novo PD patients ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2017.10.004

    authors: Siciliano M,Trojano L,De Micco R,De Mase A,Garramone F,Russo A,Tedeschi G,Tessitore A

    更新日期:2017-12-01 00:00:00

  • Nigrostriatal dopaminergic function in subjects with isolated action tremor.

    abstract:BACKGROUND:Isolated action tremor (IAT) is the hallmark clinical feature of essential tremor (ET), but it may also be a prominent feature of some individuals with Parkinson's disease (PD) suggesting a pathogenic relationship between these two disorders. OBJECTIVES:We investigated the integrity of the striatal presynap...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2011.08.025

    authors: Coria F,Gimenez-Garcia M,Samaranch L,Mora FJ,Sampol-Bas C,Pastor P

    更新日期:2012-01-01 00:00:00

  • Voxel-wise analysis of diffusion tensor MRI improves the confidence of diagnosis of corticobasal degeneration non-invasively.

    abstract::Corticobasal degeneration (CBD) presents with symptoms that often overlap with other neurological conditions. In many cases, diagnosis, prognosis and consequent clinical management remain uncertain. Structural and functional asymmetric brain changes represent the most consistent imaging findings that may assist in CBD...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2007.09.011

    authors: Bozzali M,Cercignani M,Baglio F,Scotti G,Farina E,Pugnetti L,Ashburner J,Nemni R,Falini A

    更新日期:2008-01-01 00:00:00

  • Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy.

    abstract::Serious adverse effects with antichoreic drugs can occur in patients with acute Sydenham's chorea (SC). The response to conventional treatment in severe SC may also be poor. Thus alternative therapeutic strategies have been developed. We report on four patients with severe acute SC (two with chorea paralytica and two ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2005.02.007

    authors: Teixeira AL Jr,Maia DP,Cardoso F

    更新日期:2005-08-01 00:00:00

  • Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?

    abstract::Parkinson's disease (PD) is a progressive, disabling, neurodegenerative disease that requires long term care and pharmaceutical treatment. Levodopa remains the gold standard treatment for PD globally, although it is largely unavailable and unaffordable for the majority of patients in many sub-Saharan African and other...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.03.002

    authors: Fothergill-Misbah N,Maroo H,Cham M,Pezzoli G,Walker R,Cilia R

    更新日期:2020-04-01 00:00:00

  • Analysis of diffusion tensor parameters in spinocerebellar ataxia type 3 and type 10 patients.

    abstract:INTRODUCTION:There is a dearth of studies of spinocerebellar ataxias (SCAs) and diffusion tensor magnetic resonance imaging (DTI). OBJECTIVE:To analyze changes observed in DTI parameters and correlate these to clinical findings in SCA3 and SCA10 patients. METHODS:SCA3 (n = 19) and SCA10 (n = 18) patients were compare...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.06.460

    authors: Meira AT,Arruda WO,Ono SE,Franklin GL,de Carvalho Neto A,Raskin S,Ashizawa T,Camargo CHF,Teive HAG

    更新日期:2020-09-01 00:00:00

  • Washout of chronic therapeutic deep brain stimulation increases cortical phase-amplitude coupling.

    abstract::Invasive human brain recordings have shown that acute therapeutic deep brain stimulation (DBS) reduces cortical synchronization, measured by coupling of beta phase to gamma amplitude. Here we show by noninvasive scalp electroencephalography that withdrawal of chronic DBS elevates phase-amplitude coupling, in proportio...

    journal_title:Parkinsonism & related disorders

    pub_type: 信件

    doi:10.1016/j.parkreldis.2019.08.018

    authors: Rajagopalan SS,Miller AM,de Hemptinne C,San Luciano M,Ostrem JL,Starr PA

    更新日期:2019-09-01 00:00:00

  • Progressive impairment in motor skill learning at 12 and 20 weeks post 6-OHDA- SNc lesion in rats.

    abstract::Deficiency in skilled motor activity is primarily attributed to the loss of dopaminergic neurons in the pars compacta of substantia nigra (SNc), which can be detected by performance of the rotarod test. Previous reports have demonstrated impaired skilled motor behavior in rats during the pre-motor stage of Parkinson's...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2010.12.017

    authors: Gambhir H,Mathur R,Behari M

    更新日期:2011-07-01 00:00:00

  • Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes.

    abstract:BACKGROUND:Clinical differentiation between parkinsonian syndromes (PS) remains a challenge despite well-established clinical diagnostic criteria. Specific diagnostic biomarkers have yet to be identified, though in recent years, studies have been published on the aid of certain brain related proteins (BRP) in the diagn...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2011.08.012

    authors: Bech S,Hjermind LE,Salvesen L,Nielsen JE,Heegaard NH,Jørgensen HL,Rosengren L,Blennow K,Zetterberg H,Winge K

    更新日期:2012-01-01 00:00:00

  • Moving from physician-centered care towards patient-centered care for Parkinson's disease patients.

    abstract::Today's society is changing rapidly and individuals increasingly favor an active role in designing their own lives. Contemporary patients are no exception, but the present health care system-which is organized primarily from the provider's perspective-is not yet prepared for this development. Here, we argue that an al...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2013.04.022

    authors: van der Eijk M,Nijhuis FA,Faber MJ,Bloem BR

    更新日期:2013-11-01 00:00:00

  • Striatal plasticity and extrapyramidal motor dysfunction.

    abstract::Knowledge of molecular events contributing to motor dysfunction in Parkinson's disease has advanced rapidly during the past decade. Studies in animal models as well as in patients afflicted by this disorder suggest that the nonphysiologic stimulation of striatal dopamine receptors, first as a result of dopaminergic de...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2004.02.012

    authors: Chase TN

    更新日期:2004-07-01 00:00:00

  • Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum.

    abstract::Hereditary spastic paraplegia with thin corpus callosum is a rare degenerative disease, which is characterized by a progressive weakness of the lower limbs with a hypoplastic corpus callosum, and is often associated with other symptoms such as mental impairment, amyotrophy, sensory disturbances, dysuria, nystagmus and...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2004.05.003

    authors: Kang SY,Lee MH,Lee SK,Sohn YH

    更新日期:2004-10-01 00:00:00

  • Benign hereditary chorea: an update.

    abstract::Benign hereditary chorea (BHC, MIM 118700) is a rare autosomal dominant disorder manifesting with chorea in conjunction with hypothyroidism and respiratory problems, a triad also named "brain-lung-thyroid syndrome". BHC is characterized by childhood onset with minimal or no progression into adult life and normal cogni...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2011.01.002

    authors: Inzelberg R,Weinberger M,Gak E

    更新日期:2011-06-01 00:00:00

  • Striatal dopamine transporter in different disability stages of Parkinson's disease studied with [(123)I]beta-CIT SPECT.

    abstract::Six healthy controls and eighteen patients with Parkinson's disease in different disability stages were studied with SPECT using [(123)I]beta-CIT to label the striatal dopamine transporter. The mean uptake of [(123)I]beta-CIT in the putamen was reduced to 54% of the control mean and to 65% of the average control value...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/1353-8020(95)00012-u

    authors: Rinne JO,Kuikka JT,Bergström KA,Rinne UK

    更新日期:1995-07-01 00:00:00

  • Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.

    abstract:BACKGROUND:Non-motor complications of Parkinson's disease (PD), specifically cognitive impairment, sleep disturbances, and fatigue, are recognized as important contributors to poor patient outcomes and quality of life. How sleep problems and fatigue interrelate and impact cognitive function, however, has not systematic...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2014.08.001

    authors: Goldman JG,Stebbins GT,Leung V,Tilley BC,Goetz CG

    更新日期:2014-11-01 00:00:00

  • Gaba and serotonin molecular neuroimaging in essential tremor: a clinical correlation study.

    abstract:BACKGROUND:Essential tremor is the most common movement disorder in adults, but its exact etiology and pathophysiology are still not fully understood. There is some consensus, however, about the involvement of the cerebellum and accumulating evidence points towards a dysfunction of the gabaergic system. We hypothesize ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2012.04.024

    authors: Gironell A,Figueiras FP,Pagonabarraga J,Herance JR,Pascual-Sedano B,Trampal C,Gispert JD

    更新日期:2012-08-01 00:00:00

  • Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.

    abstract::The goal of genetic association studies is to identify common (>5%) risk factors in complex disease traits. Herein we describe the first replicable 'functional' risk allele for Parkinson's disease. The leucine-rich repeat kinase 2 (Lrrk2) G2385R substitution is associated with familial parkinsonism, late-, and early-o...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2006.12.001

    authors: Farrer MJ,Stone JT,Lin CH,Dächsel JC,Hulihan MM,Haugarvoll K,Ross OA,Wu RM

    更新日期:2007-03-01 00:00:00

  • Delayed administration of dopaminergic drugs is not associated with prolonged length of stay of hospitalized patients with Parkinson's disease.

    abstract:BACKGROUND:Punctual delivery of dopaminergic medication to Parkinson's disease (PD) patients may be important in optimizing disease control. We tested the hypothesis that prompt delivery of l-dopa medications to emergency hospital inpatients was associated with a decreased length of stay in hospital. METHODS:The study...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2016.11.004

    authors: Skelly R,Brown L,Fogarty A

    更新日期:2017-02-01 00:00:00

  • Quality of sleep in young onset Parkinson's disease: Any difference from older onset Parkinson's disease.

    abstract:BACKGROUND:Sleep disorders occur commonly in Parkinson's disease and are often under-recognized and under treated in clinical practice. OBJECTIVES:To determine the quality of sleep in patients with Young onset Parkinson's disease (YOPD) and to note whether there is any difference in quality of sleep from those patient...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2015.02.007

    authors: Mahale R,Yadav R,Pal PK

    更新日期:2015-05-01 00:00:00

  • Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid.

    abstract::Diagnostic biomarkers are measures that detect or confirm the presence of a disease or identify individuals with a subtype of the disease. For Parkinson's disease, unlike other neurodegenerative diseases such as Alzheimer's disease and Creutzfeldt-Jakob disease, diagnostic biomarkers remain elusive as none are yet ava...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2018.11.016

    authors: Kalia LV

    更新日期:2019-02-01 00:00:00

  • The next chapter in symptomatic Parkinson disease treatments.

    abstract::Significant advances in the symptomatic treatment of Parkinson disease (PD) have occurred since the discovery of levodopa (LD). Perhaps as a testament to its unparalleled efficacy, novel formulations aiming to optimize LD delivery to obtain better bioavailability, longer duration of effect and less plasma level fluctu...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2019.01.002

    authors: Hengartner D,Fernandez HH

    更新日期:2019-02-01 00:00:00

  • Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus.

    abstract::The authors report one case of parkinsonism associated with systemic lupus erythematosus (SLE): a 45-year-old woman, who presented with a strategic infarct of the right substance nigra secondary to vasculitis, and contralateral symptoms. Other causes of parkinsonism were excluded. She had a partial response to therapy...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2007.08.001

    authors: Orta Daniel SJ,Ulises RO

    更新日期:2008-01-01 00:00:00

  • Prevalence survey of movement disorders, epilepsy, hypertension and smoking habit in Vejer de la Frontera, Southern Spain-I. Methodology.

    abstract::A prevalence survey of movement disorders, epilepsy, hypertension and smoking was undertaken in Vejer de la Frontera, Southern Spain in 1988. A validated screening instrument designed for door-to-door tracing of specific disorders was used. Neurological diagnoses were based on: (1) direct anamnesis and examination by ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/s1353-8020(96)00021-1

    authors: Acosta-Varo J,De Pedro-Cuesta J

    更新日期:1996-10-01 00:00:00

  • Evolution of neuropsychological profile in motor subtypes of multiple system atrophy.

    abstract:INTRODUCTION:Cognitive deficits and neuropsychiatric symptoms occur in parkinsonian and cerebellar subtypes of Multiple System Atrophy (MSA-P and MSA-C). These symptoms have been investigated mainly in cross-sectional studies. The present 1-year follow-up study aimed at evaluating the evolution of cognitive and neurops...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2019.12.010

    authors: Santangelo G,Cuoco S,Picillo M,Erro R,Squillante M,Volpe G,Cozzolino A,Cicarelli G,Barone P,Pellecchia MT

    更新日期:2020-01-01 00:00:00